Abstract: Implementations of a cryptocurrency mobile services system and method for offering a global roaming and payment procedure is provided. In some implementations, a computer-implemented method for offering these mobile services comprise receiving over a network a plurality of competing offers for mobile services from a plurality of mobile services providers computing devices, respectively. In some implementations, the method further comprises transmitting over a network one or more of the received offers for mobile services to a plurality of mobile devices, wherein for each mobile device, the offer transmitted is based on the location of the mobile device and the coverage available at the location of the mobile device. In some implementations, the method further comprises receiving over a network an indication of a response to a transmitted offer for mobile service from a mobile device.

Abstract: A laser module service shelf is generally presented. In some embodiments, a laser system includes a rack including a stack of slots to support a plurality of laser modules in first positions within the rack, wherein the rack comprises a pair of struts extending at opposite sides of an opening in the rack through which the laser modules may pass, and a module service shelf attachable to the struts to support a weight of one of the laser modules in a second position that is cantilevered from the rack in alignment with the opening and one of the slots, wherein the module service shelf comprises a plurality of detachable sections. Other embodiments are also disclosed and claimed.

Abstract: A printhead includes an address line, data lines, a fire pulse line, and a plurality of primitives, each primitive corresponding to a different data line and including a plurality of activation devices, each activation device corresponding to a different address of a set of addresses. A buffer receives data packets, each data packet including address data representative of an address of the set of addresses and print data for each primitive corresponding to the address. For each data packet, the buffer directs the address data to address logic and places the print data on the respective data line, and the address logic encodes the address represented by the address data onto the address line. For each primitive, the activation device corresponding to the address on the address bus activates a corresponding primitive function based on the corresponding print data when a fire pulse is present on the fire pulse line.

Abstract: Systems and methods are described for providing reliable biometric access control using an optical biometric sensor in a miniaturized form factor. Some implementations include multiple light sources that can illuminate skin or other tissue at multiple locations during a single measurement session. An imaging array can be arranged to form images of the light exiting the tissue only after undergoing diffuse reflectance in the tissue. Some implementations use the images to perform biometric functions. For example, the images can be used to identify an individual, verify identity of an individual, estimate demographic characteristics of an individual, etc. Such biometric functions can further be used to determine and affect access to secured assets.

Abstract: The present invention provides novel nucleotides sequences, protein sequences, immunogenic compositions, vaccines, and methods that relate to making and using new porcine parvovirus 5A (PPV5A) that infects, inter alia, domestic swine. The compositions and methods provide for the detection of infections by said new virus, monitoring genetic changes in the viral sequences in wild and domestic animals and herds, and making and using novel vaccines for protecting animals from infection by the virus.

Abstract: The present invention provides novel nucleotides sequences, protein sequences, immunogenic compositions, vaccines, and methods that relate to making and using new porcine parvovirus 5B (PPV5B) that infects, inter alia, domestic swine. The compositions and methods provide for the detection of infections by said new virus, monitoring genetic changes in the viral sequences in wild and domestic animals and herds, and making and using novel vaccines for protecting animals from infection by the virus.

Abstract: A radio transmission method which includes a steps of simulation of a phase modulation of a radio carrier by the successive transmission of a carrier of a main frequency f and of a carrier of an offset frequency f+?f, the offset frequency having a frequency difference suitable for simulating a given phase shift of the main frequency at the end of a given time T. The invention further relates to a radio transmission device for implementing the method which includes a radio integrated circuit for generating programmable frequency modulation, means for programming, in this radio integrated circuit, the main frequency f and the offset frequency f+?f and means for driving this radio integrated circuit in order to generate the frequencies as a function of the signal to be transmitted.

Abstract: The invention provides methods and mass-labeled peptides for use in said methods for quantifying the presence of a one or more viral proteins in a sample of a preparation containing agents which bind to said viral protein, using mass-spectroscopic analyses of the sample and standards containing known amounts of labeled and unlabeled signature peptides, in particular wherein said viral proteins are antigens in a vaccine for porcine circovirus.

Abstract: Methods, systems, and apparatus, including computer programs encoded on computer storage media, for processing cell images using neural networks. One of the methods includes obtaining data comprising an input image of one or more biological cells illuminated with an optical microscopy technique; processing the data using a stained cell neural network; and processing the one or more stained cell images using a cell characteristic neural network, wherein the cell characteristic neural network has been configured through training to receive the one or more stained cell images and to process the one or more stained cell images to generate a cell characteristic output that characterizes features of the biological cells that are stained in the one or more stained cell images.

Abstract: Vaccination methods to control PCV2 infection with different PCV2 subtypes are disclosed. Specifically, a PCV2 subtype b (PCV2b) ORF2 proteins or immunogenic compositions comprising a PCV2b ORF2 protein are used in a method for the treatment or prevention of an infection with PCV2 of a different subtype, the reduction, prevention or treatment of clinical signs caused by an infection with PCV2 of a different subtype, or the prevention or treatment of a disease caused by an infection with PCV2 of a different subtype.

Abstract: Apparatuses are disclosed which include a discharge lamp configured to emit ultraviolet light, a power circuit configured to operate the discharge lamp, and a reflector system configured to redirect ultraviolet light emitted from the discharge lamp. In some embodiments, the apparatuses include a support structure containing the power circuit and supporting the discharge lamp. In some of such embodiments, the reflector system is configured to redirect ultraviolet light propagating away from the support structure to a region exterior to the apparatus and which is between approximately 2 feet and approximately 4 feet from a floor of a room in which the apparatus is arranged. In other embodiments, the reflector system may be additionally or alternatively configured to redirect ultraviolet light propagating away from the support structure to encircle an exterior surface of the apparatus. In any case, the reflector system may, in some embodiments, include a repositionable reflector.

Abstract: Methods and systems for controlling power conversion systems. In one aspect, a power management system includes a first power conversion system coupled to a first energy source and a second power conversion system coupled to a second energy source, and a control system. The control system causes, while the first power conversion system is operating in an active mode and the second power conversion system is operating in a standby mode, the second power conversion system to exit the standby mode, the second power conversion system providing a reactive power flow upon exiting the standby mode. The control system causes the first power conversion system to provide a compensatory reactive power flow to compensate for at least a portion of the reactive power flow from the second power conversion system.

Abstract: Apparatus and methods for developing parallel networks. Parallel network design may comprise a general purpose language (GPC) code portion and a network description (ND) portion. GPL tools may be utilized in designing the network. The GPL tools may be configured to produce network specification language (NSL) engine adapted to generate hardware optimized machine executable code corresponding to the network description. The developer may be enabled to describe a parameter of the network. The GPC portion may be automatically updated consistent with the network parameter value. The GPC byte code may be introspected by the NSL engine to provide the underlying source code that may be automatically reinterpreted to produce the hardware optimized machine code. The optimized machine code may be executed in parallel.

Abstract: The invention provides: a method for applying a liquid to the rim of a container by transfer from a roller whose surface is composed of a tubular warp or weft knit of 2×1 rib construction; a glass jar or equivalent container whose rim has a coating of varnish, adhesion promoter or heat-sealing primer formed by an application method; a jar or equivalent container comprising a seal heat-sealed to the rim.

Abstract: The invention provides methods and mass-labeled peptides for use in said methods for quantifying the presence of a one or more viral proteins in a sample of a preparation containing agents which bind to said viral protein, using mass-spectroscopic analyzes of the sample and standards containing known amounts of labeled and unlabeled signature peptides, in particular wherein said viral proteins are antigens in a vaccine for porcine circovirus.

Abstract: The present invention is related to improved modified live PRRS vaccines containing new PRRSV European strains of PRRSV and methods of use and manufacture of such vaccines.

Abstract: The present invention relates to Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) mutant strains having increased stability; compositions containing the strains or antigens derived therefrom; vaccines containing the strains, including killed, attenuated or subunit vaccines; nucleic acids encoding PRRSV polypeptides, polypeptides encoded by the nucleic acids, including antigenic fragments thereof; antibodies which specifically bind to said polypeptides, and methods making and using thereof.

Abstract: Vaccination methods to control PCV2 infection with different PCV2 subtypes are disclosed. Specifically, a PCV2 subtype b (PCV2b) ORF2 proteins or immunogenic compositions comprising a PCV2b ORF2 protein are used in a method for the treatment or prevention of an infection with PCV2 of the same PCV2b and/or different subtype; the reduction, prevention or treatment of clinical signs caused by an infection with PCV2 of the same PCV2b or a different subtype; and/or the prevention or treatment of a disease caused by an infection with PCV2 of the same PCV2b and/or a different subtype. The present invention in particular relates to PCV2 subtype b (PCV2b) ORF2 proteins characterized in that they contain at least one mutation in the BC loop that such that the expressed protein is preferably expressed in a higher amount compared to a PCV2 ORF2 protein that does not contain such mutation.

Abstract: The present invention is related to improved modified live PRRS vaccines containing new PRRSV European strains of PRRSV and methods of use and manufacture of such vaccines.

Abstract: Vaccination methods to control PCV2 infection with different PCV2 subtypes are disclosed. Specifically, a PCV2 subtype b (PCV2b) ORF2 proteins or immunogenic compositions comprising a PCV2b ORF2 protein are used in a method for the treatment or prevention of an infection with PCV2 of the same PCV2b and/or different subtype; the reduction, prevention or treatment of clinical signs caused by an infection with PCV2 of the same PCV2b or a different subtype; and/or the prevention or treatment of a disease caused by an infection with PCV2 of the same PCV2b and/or a different subtype. The present invention in particular relates to PCV2 subtype b (PCV2b) ORF2 proteins characterized in that they contain at least one mutation in the BC loop that such that the expressed protein is preferably expressed in a higher amount compared to a PCV2 ORF2 protein that does not contain such mutation.